Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07831681Recruiting
A therapeutic game for teens with psychotic symptoms
This trial tests whether a collaborative video game can help reduce psychiatric symptoms like delusions and hallucinations in teenagers. It may also help with rigid thinking, and could be a new way to support mental health during outpatient care.
RennesAges 12–17 - NCT07826845Recruiting
Body donation for people with HHT
This study asks people with HHT (a genetic condition that causes abnormal blood vessels) to consider donating their body after death to help medical research. It aims to learn more about HHT by studying donated tissues.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT07832695Recruiting
Brain stimulation plus practice for Parkinson's disease
This study tests whether a type of brain stimulation, called repetitive transcranial magnetic stimulation (rTMS), combined with guided practice can improve movement and daily function in people with Parkinson's disease. It may help you move better and do everyday tasks more easily.
Taipei, Zhongzheng Dist.Ages 18 years+ - NCT07829081Recruiting
Watch-and-wait after immunotherapy for early-stage GI cancers
This study looks at whether some patients with early-stage stomach, colon, or rectal cancers that are mismatch repair-deficient (a genetic feature making them more likely to respond to immunotherapy) can safely avoid surgery and instead be monitored closely after treatment with immunotherapy. It aims to confirm if this watch-and-wait approach is as effective and helps patients avoid major operations.
BaselAges 18 years+ - NCT07829601Recruiting
Doctors' prevention habits study
This study looks at how doctors and medical residents prevent disease. If you are a doctor or medical resident, you can join and share your habits to help improve healthcare.
Clermont-FerrandAges Any age - NCT07827898Recruiting
Understanding pain sensitivity in tennis elbow
This study looks at how the nervous system might become more sensitive in people with long-lasting tennis elbow (lateral epicondylitis). It uses ultrasound to examine the elbow and may help doctors better understand and treat this condition.
IstanbulAges 18–65 - NCT07832188Recruiting
Brain stimulation for chronic lower back pain
This study tests a non-invasive brain stimulation technique that uses gentle electrical currents to target the part of the brain involved in pain processing. It may help reduce chronic lower back pain that is not caused by a specific injury or condition.
Jinan, ShandongAges 18–80 - NCT07830134Recruiting
Brain training for childhood medulloblastoma survivors
This study tests a brain-training method that uses real-time feedback to help improve memory and thinking in young people who survived medulloblastoma. It may help with everyday tasks like remembering things and staying focused.
Memphis, TennesseeAges 10–25 - NCT07830472Recruiting
Robot leg training for age-related muscle loss
This study tests whether a leg-training robot can help older adults with sarcopenia—a condition of losing muscle mass and strength as they age—improve their leg strength and function. The robot supports your legs during exercises, which might be safer and more effective than doing them alone.
Taipei, Taipei CityAges 60 years+ - NCT07831525Enrolling by invitation
Testing different brain currents in healthy adults
This study tests how different types of gentle electrical currents applied to the scalp affect the brain pathways that control movement. It is done in healthy adults to understand how these methods work, which may help improve future treatments for movement problems.
Porto Alegre, Rio Grande do SulAges 18–45 - NCT07828015RecruitingPhase 2
Bevacizumab for hereditary hemorrhagic telangiectasia
This trial tests whether bevacizumab, a drug that blocks blood vessel growth, can reduce bleeding in people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds.
Hangzhou, ZhejiangAges 18–75 - NCT07828080Recruiting
Hip replacement using a newer stem design
This study looks at how well a newer type of hip replacement stem (called the Actis stem) works for people having their first hip replacement. It aims to see if this stem provides good outcomes for various hip conditions.
Seongnam-si, Gyeonggi-doAges 18 years+ - NCT07833332Recruiting
Comparing two procedures for blocked small bowel in Crohn's disease
This study compares two procedures—endoscopic stricturotomy and balloon dilation—to treat a narrowed section (stricture) in the small bowel caused by Crohn's disease. If you have a partial blockage, this trial aims to see which procedure is better at safely opening the bowel.
Guangzhou, GuangdongAges 18–70 - NCT07831993RecruitingPhase 2
Immunotherapy with chemotherapy for advanced bile duct cancer
This trial tests a new combination of a drug that helps your immune system fight cancer, called sintilimab, along with chemotherapy. It is for people who have bile duct cancer or gallbladder cancer that has spread to other parts of the body and have not had treatment for this stage yet. The goal is to see if this combination helps shrink tumors or stops them from growing.
Nanjing, JiangsuAges 18–75 - NCT04842812RecruitingPhase 1
Personalized immune cell therapy for advanced solid tumors
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
GuangzhouAges 18–85 - NCT03778814RecruitingPhase 1
Personalized T-cell therapy for advanced lung or solid tumors
This Phase 1 study tests a lab-made immune cell treatment made from your own blood cells (T cells) to fight advanced lung cancer or other solid tumors. You may be eligible if your tumor can be biopsied and the lab can successfully prepare T cells that strongly recognize and attack your cancer.
Guanzhou, GuangdongAges 18–75 - NCT04803318RecruitingPhase 2
Test of three targeted medicines for advanced solid tumors
This Phase 2 study tests trametinib plus everolimus plus lenvatinib in people with advanced solid tumors that have come back or cannot be treated anymore. It aims to control tumor growth and symptoms when standard options have not worked.
Guangzhou, GuangdongAges 18–85 - NCT03192501Recruiting
Using prior scans to guide cancer treatment choices
This trial tests whether using existing “PACS” scan images to guide individualized cancer treatment (compared with standard care) can improve outcomes for people with advanced or metastatic cancer. It may help doctors make more precise treatment decisions using your past imaging.
Guangzhou, GuangdongAges 18–70 - NCT05779917RecruitingPhase 1
CAR-T cells for cancers that have specific target proteins
This Phase 1 trial tests a customized immune therapy (CAR-T cells) for advanced cancers that have the proteins mesothelin, GPC3, and/or GUCY2C. It may help your body better recognize and kill cancer cells, but early-phase trials mainly focus on safety and learning how well the treatment works.
Guangzhou, GuangdongAges 18–75 - NCT03198052RecruitingPhase 1
CAR-T cell therapy for cancers with specific protein targets
This Phase 1 study tests CAR-T cells that are engineered to recognize several cancer “markers” (specific proteins) found on some advanced cancers. It may help by directing the patient’s own immune cells to attack cancer, but eligibility depends on matching the required protein markers.
Guangzhou, GuangdongAges 18–75 - NCT03755739RecruitingPhase 2/Phase 3
Checkpoint cancer drug given into or near tumors
This trial studies whether giving immunotherapy “checkpoint inhibitor” medicine directly into the tumor area (and/or the artery feeding it), along with a chemotherapy-style drug, can work better for advanced solid tumors. It aims to boost the immune system’s ability to attack cancer while still being safe for people with measurable tumors.
Guanzhou, GuangdongAges 18 years+ - NCT05187338RecruitingPhase 1/Phase 2
Study drugs that target immune checkpoints for solid tumors
This early-phase study tests a combination of three immune “checkpoint” medicines in people with advanced solid cancers. It aims to see how well they work and what side effects occur, including when given through a specific liver-focused treatment in eligible patients.
Guangzhou, GuangdongAges 18–70 - NCT05060796RecruitingEarly Phase 1
CAR-T treatment for advanced lung cancer with EGFR and CXCL13 signs
This early-phase study tests a custom CAR-T cell therapy made to target EGFR in people with advanced non-small cell lung cancer. You may be eligible if your tumor has specific lab markers (EGFR and CXCL13) and if your overall heart, liver, kidney, and blood counts can safely support treatment.
GuangzhouAges 18–75 - NCT05341492RecruitingEarly Phase 1
CAR-T therapy for EGFR/B7H3-positive lung and triple-negative breast cancer
This early-phase trial tests CAR-T cells designed to find and attack tumors that show EGFR or B7H3 markers. It may help people with advanced lung cancer or triple-negative breast cancer after standard treatments.
Guangzhou, GuangdongAges 18–75
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,157 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.